Table 1 The age-standardized global incidence and number of cancer cases attributable to viral infections in 2022, by oncoviruses and geographical region
From: Viral oncogenesis in cancer: from mechanisms to therapeutics
Region | HPV | HBV | HCV | EBV | KSHV | HTLV-1 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASIR | NNC | ASIR | NNC | ASIR | NNC | ASIR | NNC | ASIR | NNC | ASIR | NNC | |
Africa | 30.0 | 137,000 | 4.6 | 40,000 | 2.3 | 21000 | 1.1 | 24,000 | 2.3 | 27,000 | - | <500 |
Latin America and the Caribbean | 18.5 | 75,000 | 2.7 | 23,000 | 1.1 | 9700 | 0.2 | 8300 | 0.4 | 2800 | - | <500 |
Northern America | 14.1 | 40,000 | 3.7 | 26,000 | 2.6 | 19000 | 0.3 | 5800 | 0.2 | 1200 | - | <1000 |
Europe | 17.2 | 99,000 | 2.8 | 48,000 | 1.9 | 31000 | 0.3 | 12,000 | 0.2 | 2700 | - | <1000 |
Pacific Ocean | 15.4 | 4400 | 4.1 | 2600 | 1.8 | 1100 | 0.4 | <500 | 0.1 | <100 | - | <100 |
Asia | 16.1 | 460,000 | 5.5 | 330,000 | 2.5 | 150000 | 1.8 | 120,000 | 0.1 | 2500 | - | 2000 |
Global | 18.5 | 820,000 | 3.9 | 470,000 | 2.0 | 230000 | 1.4 | 170,000 | 0.4 | 36,000 | - | 4000 |
